课题基金 / 基金详情

Extl3缓解1型糖尿病胰岛β细胞破坏的作用与机制研究

批准号:
82000740
项目类别:
青年科学基金项目
资助金额:
24.0 万元
负责人:
刘得辰
依托单位:
学科分类:
胰岛生理调控与功能异常
结题年份:
2023
批准年份:
2020
项目状态:
已结题
项目参与者:
刘得辰

项目摘要

结项摘要

项目成果

相似基金

相关文献

中文摘要
1型糖尿病是一种慢性自身免疫性疾病,存在异常激活的免疫细胞破坏胰岛基底膜而侵入胰岛并攻击β细胞的现象。作为参与基底膜中硫酸乙酰肝素合成的关键基因,外生骨疣样蛋白3(Extl3)不仅对β细胞成熟起关键作用,而且在β细胞受到IL-1β等炎症因子刺激后表达水平迅速下调。通过实验我们发现,小鼠胰腺原位注射shExtl3腺相关病毒可下调β细胞内Extl3的蛋白水平,并加重链脲佐菌素(STZ)诱导的胰岛炎及胰岛功能损伤,提示Extl3在1型糖尿病发病过程中可能起重要作用,但机制仍不清楚。申请人拟于1型糖尿病模型小鼠β细胞中特异性敲降或过表达Extl3,验证Extl3通过促进硫酸乙酰肝素合成而缓解β细胞的免疫损伤;利用谱系示踪实验,观测Extl3在1型糖尿病β细胞去分化中的作用;细胞水平上借助炎症因子刺激,进一步探究Extl3表达水平下调介导β细胞损伤的分子机制。希望本研究能为1型糖尿病防治带来新思路。
英文摘要
Type 1 diabetes is a chronic autoimmune disease, in which abnormally activated immune cells destroy the basement membrane, infiltrate the islets, and attack the β cells. As a key gene for heparan sulfate synthesis in the islet basement membrane, exostoses-like 3 protein (Extl3) plays a key role in β-cell maturation and inflammatory factors such as IL-1β rapidly decreases the expression of Extl3 in β-cells. Additionally, we found that in situ injection of shExtl3 adeno-associated virus in mouse pancreas can down-regulate the protein level of Extl3 in pancreatic β cells, and aggravate insulitis and islet function damage induced by streptozotocin (STZ). The facts suggest that Extl3 might play an important role in the pathogenesis of type 1 diabetes, but the mechanism is still to be deciphered. This study intends to use specific knockdown or overexpression of Extl3 in β cells of type 1 diabetes model mice to verify that Extl3 mitigates immune damage to β cells by promoting heparan sulfate synthesis; The lineage tracing study is used to observe that the function of Extl3 in β-cell dedifferentiation; The molecular mechanism of Extl3 downregulation mediating β-cell injury is further explored by treatment of inflammatory factors. The study would bring new ideas for the prevention and treatment of type 1 diabetes.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI: 10.1002/adfm.202211897
发表时间: 2023-02
期刊: Advanced Functional Materials
影响因子: 19
作者: [Ji Sun;Jingbo Li;Zhikun Huan;S. Pandol;Dechen Liu;Luoran Shang;Ling Li]
通讯作者: Ji Sun;Jingbo Li;Zhikun Huan;S. Pandol;Dechen Liu;Luoran Shang;Ling Li
DOI: 10.1016/j.mce.2022.111653
发表时间: 2022-05
期刊: Molecular and Cellular Endocrinology
影响因子: 4.1
作者: [Xiangyun Zhu;Dechen Liu;Guoqing Li;Mengmeng Zhi;Ji Sun;Liang Qi;Jingbo Li;S. Pandol;Ling Li]
通讯作者: Xiangyun Zhu;Dechen Liu;Guoqing Li;Mengmeng Zhi;Ji Sun;Liang Qi;Jingbo Li;S. Pandol;Ling Li
DOI: 10.1016/j.diabet.2021.101316
发表时间: 2021-12
期刊: Diabetes & metabolism
影响因子: 7.2
作者: [Liang Qi;Qiong Wei;Muhan Ni;Dechen Liu;Jiantong Bao;Yingqi Lv;Hong Xia;Qian Wang;Lei Wang;Jianhua Su;Pandol Sj;Ling Li]
通讯作者: Liang Qi;Qiong Wei;Muhan Ni;Dechen Liu;Jiantong Bao;Yingqi Lv;Hong Xia;Qian Wang;Lei Wang;Jianhua Su;Pandol Sj;Ling Li
DOI: 10.3389/fendo.2022.839865
发表时间: 2022
期刊: Frontiers in endocrinology
影响因子: 5.2
作者: []
通讯作者:
7
    国内基金
    海外基金